Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation

Trans-(-)-ε-viniferin (ε-viniferin) has antioxidative and anti-inflammatory effects. It also has neuroprotective effects in Huntington’s disease by activating the SIRT3/LKB1/AMPK signaling pathway; however, it remains unknown whether ε-viniferin also has a neuroprotective role in Parkinson’s disease...

Full description

Bibliographic Details
Main Authors: Shuo Zhang, Yan Ma, Juan Feng
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2143;epage=2153;aulast=Zhang
_version_ 1818139800870322176
author Shuo Zhang
Yan Ma
Juan Feng
author_facet Shuo Zhang
Yan Ma
Juan Feng
author_sort Shuo Zhang
collection DOAJ
description Trans-(-)-ε-viniferin (ε-viniferin) has antioxidative and anti-inflammatory effects. It also has neuroprotective effects in Huntington’s disease by activating the SIRT3/LKB1/AMPK signaling pathway; however, it remains unknown whether ε-viniferin also has a neuroprotective role in Parkinson’s disease. A Parkinson’s disease cell model was induced by exposing SH-SY5Y cells to 3.0 μM rotenone for 24 hours, and cells were then treated with 1.0 μM ε-viniferin for 24 hours. Treatment with ε-viniferin upregulated SIRT3 expression, which promoted FOXO3 deacetylation and nuclear localization. ε-Viniferin also increased ATP production and decreased reactive oxygen species production. Furthermore, ε-viniferin treatment alleviated rotenone-induced mitochondrial depolarization and reduced cell apoptosis, and restored the expression of mitochondrial homeostasis-related proteins. However, when cells were transfected with SIRT3 or FOXO3 shRNA prior to rotenone and ε-viniferin treatment, these changes were reversed. The results from the present study indicate that ε-viniferin enhances SIRT3-mediated FOXO3 deacetylation, reduces oxidative stress, and maintains mitochondrial homeostasis, thus inhibiting rotenone-induced cell apoptosis. ε-Viniferin may therefore be a promising treatment strategy for Parkinson’s disease.
first_indexed 2024-12-11T10:33:51Z
format Article
id doaj.art-555c8719efca42c4ae28e8aab2a2039f
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-11T10:33:51Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-555c8719efca42c4ae28e8aab2a2039f2022-12-22T01:10:48ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742020-01-0115112143215310.4103/1673-5374.282264Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylationShuo ZhangYan MaJuan FengTrans-(-)-ε-viniferin (ε-viniferin) has antioxidative and anti-inflammatory effects. It also has neuroprotective effects in Huntington’s disease by activating the SIRT3/LKB1/AMPK signaling pathway; however, it remains unknown whether ε-viniferin also has a neuroprotective role in Parkinson’s disease. A Parkinson’s disease cell model was induced by exposing SH-SY5Y cells to 3.0 μM rotenone for 24 hours, and cells were then treated with 1.0 μM ε-viniferin for 24 hours. Treatment with ε-viniferin upregulated SIRT3 expression, which promoted FOXO3 deacetylation and nuclear localization. ε-Viniferin also increased ATP production and decreased reactive oxygen species production. Furthermore, ε-viniferin treatment alleviated rotenone-induced mitochondrial depolarization and reduced cell apoptosis, and restored the expression of mitochondrial homeostasis-related proteins. However, when cells were transfected with SIRT3 or FOXO3 shRNA prior to rotenone and ε-viniferin treatment, these changes were reversed. The results from the present study indicate that ε-viniferin enhances SIRT3-mediated FOXO3 deacetylation, reduces oxidative stress, and maintains mitochondrial homeostasis, thus inhibiting rotenone-induced cell apoptosis. ε-Viniferin may therefore be a promising treatment strategy for Parkinson’s disease.http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2143;epage=2153;aulast=Zhangdeacetylation; foxo3; mitochondrial homeostasis; mitophagy; oxidative stress; parkinson’s disease; sirt3; ε-viniferin
spellingShingle Shuo Zhang
Yan Ma
Juan Feng
Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
Neural Regeneration Research
deacetylation; foxo3; mitochondrial homeostasis; mitophagy; oxidative stress; parkinson’s disease; sirt3; ε-viniferin
title Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
title_full Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
title_fullStr Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
title_full_unstemmed Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
title_short Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
title_sort neuroprotective mechanisms of ε viniferin in a rotenone induced cell model of parkinson s disease significance of sirt3 mediated foxo3 deacetylation
topic deacetylation; foxo3; mitochondrial homeostasis; mitophagy; oxidative stress; parkinson’s disease; sirt3; ε-viniferin
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2143;epage=2153;aulast=Zhang
work_keys_str_mv AT shuozhang neuroprotectivemechanismsofeviniferininarotenoneinducedcellmodelofparkinsonsdiseasesignificanceofsirt3mediatedfoxo3deacetylation
AT yanma neuroprotectivemechanismsofeviniferininarotenoneinducedcellmodelofparkinsonsdiseasesignificanceofsirt3mediatedfoxo3deacetylation
AT juanfeng neuroprotectivemechanismsofeviniferininarotenoneinducedcellmodelofparkinsonsdiseasesignificanceofsirt3mediatedfoxo3deacetylation